Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Korosho to Order Revision of Package Insert for All Antidepressants
November 5, 2007
- Chugai to Place Top Priority on Proper Use of Tarceva
November 5, 2007
- Telavancin Received FDA Approvable Letter: Astellas
November 5, 2007
- Chugai's Operating Profits Up 24% in First 3 Qtr
November 5, 2007
- Nexavar, Zevalin, Gracevit, Prezista Recommended for Approval
November 5, 2007
- SEMINAR
November 5, 2007
- Lonasen, Clexane, Amage Recommended for Approval
November 5, 2007
- Korosho Found to Have Identifying Information on 118 Hepatitis C Patients
November 5, 2007
- BUSINESS NEWS IN BRIEF
November 5, 2007
- Gastric Cancer GL Stress Use of TS-1 for Inoperable Patients
November 5, 2007
- Kirin HD-Kyowa Hakko Deal Beneficial for Kirin HD, Neutral for Kyowa Hakko's Shareholders: DIR Report
November 5, 2007
- Defensive Factor Enhancing Agents Not Recommended after Endoscopic Therapy
November 5, 2007
- Mr Sekiguchi Explains PhRMA's Stance Regarding NHI Pricing
November 5, 2007
- MEDICAL DEVICE NEWS IN BRIEF
November 5, 2007
- Novartis to Cut 1,260 Jobs in the US
November 5, 2007
- R&D NEWS IN BRIEF
November 5, 2007
- GSK to Save ￡700 Mil. Each Year from 2010
November 5, 2007
- GNI's 3 Genes/Proteins Patented in China
November 5, 2007
- Hub Customization System Reduces Transportation Cost: Eli Lilly
November 5, 2007
- Lu AA24530 Enters PII in Europe: Takeda
November 5, 2007
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…